RAC 0.60% $1.69 race oncology ltd

Oncology - Pharma Deals News, page-135

  1. 11,249 Posts.
    lightbulb Created with Sketch. 29637
    Posted by @RitzyBusiness:

    In broader industry news...

    Merck takes a swing at the IL-2 puzzlebox with a $1.85B play for buzzy Pandion and its autoimmune hopefuls – Endpoints News (endpts.com)

    • all-cash deal is equivalent to $60 per share, a roughly 134% premium on Pandion’s Wednesday closing price
    • remarkable ROI for Pandion investors after the biotech went public back in July for just $135 million. That big jump partly underscores the sort of crazy money floating around in biotech
    • pharma giant’s (Merck's) intent to continue the search for the next big Keytruda follow-up...
    • Merck’s next-gen search for oncology blockbusters.


    https://hotcopper.com.au/posts/51343658/single

    see also:

    https://hotcopper.com.au/posts/51344381/single
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.69
Change
0.010(0.60%)
Mkt cap ! $287.1M
Open High Low Value Volume
$1.69 $1.70 $1.65 $89.01K 53.2K

Buyers (Bids)

No. Vol. Price($)
1 2342 $1.69
 

Sellers (Offers)

Price($) Vol. No.
$1.70 5 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.